Stock analysts at Investec began coverage on shares of Georgia Healthcare Group PLC (LON:GHG) in a report released on Wednesday. The firm set a “buy” rating and a GBX 361 ($4.71) price target on the stock. Investec’s price objective would suggest a potential upside of 14.60% from the stock’s previous close.
Other analysts have also issued reports about the stock. Jefferies Group upped their price target on shares of Georgia Healthcare Group PLC from GBX 280 ($3.65) to GBX 395 ($5.16) and gave the stock a ” buy” rating in a research note on Tuesday, July 26th. Numis Securities Ltd reaffirmed a “buy” rating and issued a GBX 355 ($4.63) price target on shares of Georgia Healthcare Group PLC in a research note on Friday, September 2nd.
Georgia Healthcare Group PLC (LON:GHG) opened at 310.00 on Wednesday. The firm has a 50-day moving average of GBX 298.66 and a 200-day moving average of GBX 258.98. Georgia Healthcare Group PLC has a one year low of GBX 145.00 and a one year high of GBX 350.00. The stock’s market capitalization is GBX 397.36 million.
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.